These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33353723)

  • 21. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
    Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment.
    Banerjee G; Wilson D; Jäger HR; Werring DJ
    Biochim Biophys Acta; 2016 May; 1862(5):926-38. PubMed ID: 26687324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
    Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
    J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic imaging techniques in the investigation of dementia].
    Øksengård AR; Haakonsen M; Dullerud R; Babovic A; Laake K; Engedal K
    Tidsskr Nor Laegeforen; 2002 Mar; 122(7):710-4. PubMed ID: 11998736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
    Ferrari BL; Neto GCC; Nucci MP; Mamani JB; Lacerda SS; Felício AC; Amaro E; Gamarra LF
    Medicine (Baltimore); 2019 Nov; 98(45):e17824. PubMed ID: 31702636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
    Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of static brain lesions in vascular dementia: implications for clinical trials.
    Erkinjuntti T; Bowler JV; DeCarli CS; Fazekas F; Inzitari D; O'Brien JT; Pantoni L; Rockwood K; Scheltens P; Wahlund LO; Desmond DW
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S81-90. PubMed ID: 10609686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
    Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
    Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of SaiLuoTong (MLC-SLT) development in vascular cognitive impairment and dementia.
    Ampil ER; Ong PA; Krespi Y; Yang YH
    Front Pharmacol; 2024; 15():1343820. PubMed ID: 38751782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping.
    Yang DW; Kim BS; Park JK; Kim SY; Kim EN; Sohn HS
    J Neurol Sci; 2002 Nov; 203-204():199-205. PubMed ID: 12417384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
    Helman AM; Murphy MP
    Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia.
    Yoshikawa T; Murase K; Oku N; Imaizumi M; Takasawa M; Rishu P; Kimura Y; Ikejiri Y; Kitagawa K; Hori M; Hatazawa J
    AJNR Am J Neuroradiol; 2003 Aug; 24(7):1341-7. PubMed ID: 12917125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact and diagnostic accuracy of 2-[
    Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
    Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of imaging techniques in the diagnosis of dementia.
    O'Brien JT
    Br J Radiol; 2007 Dec; 80 Spec No 2():S71-7. PubMed ID: 18445747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.